Diabetische Nephropathie: Aktuelle Diagnostik und Therapie

Translated title of the contribution: Diabetic nephropathy: Current diagnostics and treatment

S. Werth, H. Lehnert, J. Steinhoff*

*Corresponding author for this work
3 Citations (Scopus)


Diabetic kidney disease is a leading cause of renal failure in Germany. Albuminuria is an early diagnostic indicator of renal damage in diabetes and, aside from renal failure, a major risk factor of cardiovascular disease. An early diagnosis of diabetic kidney disease is of great importance to reduce associated cardiovascular mortality; glycemic control should aim for HbA1c levels of < 7 %. Guidelines on blood pressure differ, but it should generally be reduced to < 140/90 mmHg; stricter limits should be applied if albuminuria is present. ACE inhibitors (ACE-I) or angiotensin receptor blockers (ARB) should be preferred for blood pressure control. A combination of ACE-Is and ARBs or a renin-inhibitor therapy does not improve cardiovascular outcome, instead it increases the rate of adverse events, e.g., hyperkalemia or renal failure. Lipid control, usually with statins, should be started at an early phase of renal failure. Vitamin D receptor activation and uric acid reduction might play a future role in the treatment of diabetic kidney disease. Pharmacological modification of inflammatory signaling appears to be promising but is not yet of clinical relevance.

Translated title of the contributionDiabetic nephropathy: Current diagnostics and treatment
Original languageGerman
Issue number5
Pages (from-to)513-519
Number of pages7
Publication statusPublished - 01.05.2015


Dive into the research topics of 'Diabetic nephropathy: Current diagnostics and treatment'. Together they form a unique fingerprint.

Cite this